
Germ-specific diagnosis is hard
but necessary
Inappropriate treatment does not prevent hospitalization (40%, of >65 with pneumonia end up hospitalized), and antibiotic misuse leads to antimicrobial resistance





02
Doctors can diagnose
pneumonia, but cannot
easily identify the underlying
microorganism
03
By guidelines, they must prescribe broad-spectrum antibiotics to every patient, despite 50% are actually viral
04
Inappropriate treatment does not prevent the patient from ending up hospitalized (cost > $30k /patient)
01
Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide
05
Antibiotic overuse leads to antimicrobial resistance (AMR), #1 world cause of death by 2050
Germ-specific diagnosis is hard
but necessary
Inappropriate treatment does not prevent hospitalization (40%, of >65 with pneumonia end up hospitalized), and antibiotic misuse leads to antimicrobial resistance
Antibiotic overuse leads to antimicrobial resistance (AMR), #1 world cause of death by 2050

05

04
Inappropriate treatment does not prevent the patient from ending up hospitalized (cost > $30k /patient)
03
By guidelines, they must prescribe broad-spectrum antibiotics to every patient, despite 50% are actually viral

Doctors can diagnose
pneumonia, but cannot
easily identify the underlying
microorganism
02


01
Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide
01
Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide




02
Doctors can diagnose
pneumonia, but cannot
easily identify the underlying
microorganism
03
By guidelines, they must prescribe broad-spectrum antibiotics to every patient, despite 50% are actually viral
04
Inappropriate treatment does not prevent the patient from ending up hospitalized (cost > $30k /patient)
01
Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide
05
Antibiotic overuse leads to antimicrobial resistance (AMR), #1 world cause of death by 2050
Our Team
Jordan Parker

Position / Role
Max Johnson

Position / Role
Drew Carlyle

Position / Role
Morgan James

Position / Role

Any sample works
Compatible with respiratory swab, blood, urine, saliva, stool…
Point of care
Can sit on a desk, no lab required
Fast
Result in 10-15 minutes
Cheap
Device intrinsic value
< $10,000, consumables
< $50 /test
Quantitative
Customizable panel of 50+ viruses, bacteria, and fungi in 1 test

One test to rule them all

Any sample works
Compatible with respiratory swab, blood, urine, saliva, stool…
Point of care
Can sit on a desk, no lab required
Fast
Result in 10-15 minutes
Cheap
Device intrinsic value
< $10,000, consumables
< $50 /test
Quantitative
Customizable panel of 50+ viruses, bacteria, and fungi in 1 test
Point of care
Can sit on a desk, no lab required
Fast
Result in 10-15 minutes
Cheap
Device intrinsic value
< $10,000, consumables
< $50 /test
Quantitative
Customizable panel of 50+ viruses, bacteria, and fungi in 1 test

One test to rule them all
About

We are developing a quantitative analysis capable of detecting all microrganisms in both clinical and non-clinical samples, using a fast and cheap technology which can be deployed at the point of care.


How it works





Competitor approaches

Meet the team
Giulio Deangeli

MD, PhDc, MBiotech, MMedSci, BEng
2024 - Final year PhD student, University of Cambridge
2021 - «100 number ones» by Forbes
2020 - 5 university courses in parallel, 30/30 GPA
2018 - Harvard HIP Scholarship, ranked in top 5%
2016 - Amgen Scholarship, Cambridge, ranked #1
2013 - World Vice-Champion Neuroscience, IBB
Author of 2 books; papers in Science and in Brain.
Cristiano Peron

MD, PhD
2023 - PhD, University of Oxford
2023 - Clinical Fellow Oxford University Hospital
2021 - Old Silver VC Fellow, Boston
2019 - Medical Doctor, summa cum laude
2018 - Armenise-Harvard Fellowship, Harvard univ.
2017 - IEF Fellowship, Columbia university
Papers in peer reviewed journals
Ulrich Keyser

MEeng, PhD
2016 - Professor of Applied Physics, Cavendish Lab, University of Cambridge
2015 - ERC consolidator grant winner
2010 - ERC starting grant winner
2006 - Emmy Noether award as a group leader, Leipzing University
2006 - Performed the first direct force measurement on DNA in a solid-state nanopore (Nature physics)
Meet the team